Author: Vijay Kumar Malesu

A 68-week phase 3 trial found that coadministered cagrilintide and semaglutide led to significant and clinically meaningful weight loss in adults with obesity but no diabetes. The combination outperformed either drug alone and improved multiple cardiometabolic health markers.Read More

Broadcom Inc. (NASDAQ:AVGO) is one of the 10 Technology Dividend Aristocrats to Buy in 2025. The stock’s value has grown significantly in recent years thanks to its leadership in global connectivity and the rising demand for artificial intelligence (AI). Broadcom Inc. (NASDAQ:AVGO) serves multiple end markets such as cloud infrastructure, networking, cybersecurity, storage, broadband, wireless, […]Read More

New book: Early decisions had big consequences.Read More

The sky is the limit for students in Forsyth Tech’s Aviation Technology ProgramRead More

Jeff Bezos and Lauren Sánchez upcoming Venice wedding was met with protests in the city, with locals citing concerns about overtourism.Read More

Despite assuming control, Kehoe clarified that the department will remain under Chief Tracy.Read More

Business owners in the Matanuska area are preparing for more rainfall in the coming days after a weekend of flooding.Read More

CITY & BUSINESS OFFICIALS ANNOUNCE LAND DONATION FOR SPORTS COMPLEX AND DEVELOPMENT **Mayor to seek Council support for $5 Million in Vi…Read More

“We will be better monitor the crowds coming and leaving and count the people if we need to in the facility,” one commissioner said.Read More

The DOJ filed legal action over a law that requires clergy to report instances of child abuse or neglect, claiming the law is “anti-Catholic.”Read More